NovaLink was established in 1992 and is a leading supplier of chemical products and services. It primarily serves the global pharmaceutical, pesticide, flavor and fragrance, and specialty chemicals industries.

NovaLink operates multiple R&D centers and production bases in China. The company focuses on the research, production, and sales of active pharmaceutical ingredients (APIs) and intermediates for anti-tumor drugs, antipsychotic drugs, anti-diabetic drugs, and cardiovascular drugs; daily chemical and food flavors; pesticide technical materials and their intermediates; as well as daily chemicals and paper chemicals. Its business spans over 80 countries and regions worldwide. NovaLink also plans to establish new R&D and production bases in China in the future to meet the growing demands of customers globally.

NovaLink is committed to providing customers with comprehensive one-stop services that cover the entire product lifecycle, from laboratory research and development, pilot testing, to commercial production. It strives to meet the diverse needs of customers at different stages, helping them shorten product development cycles, reduce R&D and production costs, and ultimately achieve mutual success.

In the future, NovaLink will implement strategic development to build large-scale products and services, expand networked channel coverage and terminal marketing; innovate business models, integrate industrial chain resources, comprehensively enhance competitiveness and profitability, and become a sustainable green innovation-driven enterprise with core competitiveness.